Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-

Hemoglobin Drift After Cardiac Surgery

(2012) Timothy J. George et al.   ANNALS OF THORACIC SURGERY

The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial

(2012) P. Garrido-Martin et al.   Interactive Cardiovascular and Thoracic Surgery

Oral Ferrous Sulfate Does Not Increase Preoperative Hemoglobin in Patients Scheduled for Hip or Knee Arthroplasty

(2011) Kim Lachance et al.   ANNALS OF PHARMACOTHERAPY

A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery

(2011) E. Bisbe et al.   BRITISH JOURNAL OF ANAESTHESIA

The Association of Perioperative Red Blood Cell Transfusions and Decreased Long-Term Survival After Cardiac Surgery

(2009) Stephen D. Surgenor et al.   ANESTHESIA AND ANALGESIA

Perioperative anaemia management: consensus statement on the role of intravenous iron

(2008) P. Beris et al.   BRITISH JOURNAL OF ANAESTHESIA